-transparent.png){kind=logo}
Psoriasis is a frequent multifactorial chronic skin disease that can lead to a decreased quality of life. Some patients also present arthritis. Those two complex inflammatory diseases share some of their characteristics, but several clinical manifestations can be distinguished in each of them. In addition to classical medications (constituted of topical treatments, methotrexate, ciclosporin and retinoids for cutaneous psoriasis and non steroidal anti-inflammatory drugs or methotrexate for psoriatic arthritis), they are the target of a new generation of therapies: the biologics.
Related Publications
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
September 1955,
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
March 2017,
The Journal of clinical and aesthetic dermatology,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
February 2006,
The Journal of rheumatology,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
February 1999,
Praxis,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
August 2009,
The Journal of rheumatology. Supplement,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
January 2004,
Dermatologic therapy,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
August 1977,
Vestnik dermatologii i venerologii,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
June 2016,
The American journal of managed care,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
June 2016,
The American journal of managed care,
A Henno, and
A Rausin, and
M Malaise, and
M de la Brassinne
March 1994,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
